[
1. Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis 2019;38(7):1211-21.10.1007/s10096-019-03539-6
]Search in Google Scholar
[
2. Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015;372(16):1539-48.10.1056/NEJMra1403772
]Search in Google Scholar
[
3. Evans CT, Safdar N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin Infect Dis 2015;60 Suppl 2:S66-71.10.1093/cid/civ140
]Search in Google Scholar
[
4. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. Mechanisms of action of probiotics: Recent advances. Inflamm Bowel Dis 2009;15(2):300-10.10.1002/ibd.20602
]Search in Google Scholar
[
5. Cremonini F, Di Caro S, Santarelli L, Gabrielli M, Candelli M, Nista EC, et al. Probiotics in antibiotic-associated diarrhoea. Dig Liver Dis 2002;34 Suppl 2:S78-80.10.1016/S1590-8658(02)80171-2
]Search in Google Scholar
[
6. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000;130(2S Suppl):396S-402S.10.1093/jn/130.2.396S10721914
]Search in Google Scholar
[
7. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JNV, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012;307(18):1959-69.10.1001/jama.2012.350722570464
]Search in Google Scholar
[
8. Goldenberg JZ, Yap C, Lytvyn L, Lo CKF, Beardsley J, Mertz D, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2017;12(12):CD006095.10.1002/14651858.CD006095.pub4648621229257353
]Search in Google Scholar
[
9. Ma Y, Yang JY, Peng X, Xiao KY, Xu Q, Wang C. Which probiotic has the best effect on preventing Clostridium difficile-associated diarrhea? A systematic review and network meta-analysis. J Dig Dis 2020;21(2):69-80.10.1111/1751-2980.1283931875427
]Search in Google Scholar
[
10. Thornhill MH, Dayer MJ, Durkin MJ, Lockhart PB, Baddour LM. Risk of adverse reactions to oral antibiotics prescribed by dentists. J Dent Res 2019;98(10):1081-7. doi: 10.1177/0022034519863645.10.1177/0022034519863645825624731314998
]Search in Google Scholar
[
11. Aabed K, Shafi Bhat R, Moubayed N, Al-Mutiri M, Al-Marshoud M, Al-Qahtani A, et al. Ameliorative effect of probiotics (Lactobacillus paracaseii and Protexin®) and prebiotics (propolis and bee pollen) on clindamycin and propionic acid-induced oxidative stress and altered gut microbiota in a rodent model of autism. Cell Mol Biol (Noisy-le-grand) 2019;65(1):1-7.10.14715/cmb/2019.65.1.1
]Search in Google Scholar
[
12. Wei Y, Yang F, Wu Q, Gao J, Liu W, Liu C, et al. Protective effects of bifidobacterial strains against toxigenic Clostridium difficile. Front Microbiol 2018;9:888.10.3389/fmicb.2018.00888595218529867801
]Search in Google Scholar
[
13. Xu Q, Gu S, Chen Y, Quan J, Lv L, Chen D, et al. Protective effect of Pediococcus pentosaceus LI05 against Clostridium difficile infection in a mouse model. Front Microbiol 2018;9:2396.10.3389/fmicb.2018.02396618940030356740
]Search in Google Scholar
[
14. Golić N, Veljović K, Popović N, Djokić J, Strahinić I, Mrvaljević I, et al. In vitro and in vivo antagonistic activity of new probiotic culture against Clostridium difficile and Clostridium perfringens. BMC Microbiol 2017;17(1):108.10.1186/s12866-017-1015-5542040528477627
]Search in Google Scholar
[
15. Evans M, Salewski RP, Christman MC, Girard SA, Tompkins TA. Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2016;116(1):94-103.10.1017/S000711451600166527169634
]Search in Google Scholar
[
16. Barker AK, Duster M, Valentine S, Hess T, Archbald-Pannone L, Guerrant R, et al. A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO). J Antimicrob Chemother 2017;72(11):3177-80.10.1093/jac/dkx254589071128961980
]Search in Google Scholar
[
17. McFarland LV, Surawicz CM, Greenberg RN, Fekety R, Elmer GW, Moyer KA, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271(24):1913-8.10.1001/jama.1994.03510480037031
]Search in Google Scholar
[
18. Kabbani TA, Pallav K, Dowd SE, Villafuerte-Galvez J, Vanga RR, Castillo NE, et al. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes 2017;8(1):17-32.10.1080/19490976.2016.1267890534191427973989
]Search in Google Scholar
[
19. Tariq R, Pardi DS, Bartlett MG, Khanna S. Low cure rates in controlled trials of fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Clin Infect Dis 2019;68(8):1351-8. doi: 10.1093/cid/ciy721.10.1093/cid/ciy72130957161
]Search in Google Scholar
[
20. Lee CH, Steiner T, Petrof EO, Smieja M, Roscoe D, Nematallah A, et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 2016;315(2):142-9.10.1001/jama.2015.1809826757463
]Search in Google Scholar
[
21. Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, et al. Systematic review: adverse events of fecal microbiota transplantation. PLoS One 2016;11(8):e0161174.10.1371/journal.pone.0161174498696227529553
]Search in Google Scholar
[
22. Grigoryan Z, Shen MJ, Twardus SW, Beuttler MM, Chen LA, Bateman-House A. Fecal microbiota transplantation: uses, questions, and ethics. Med Microecol 2020;6:100027.10.1016/j.medmic.2020.100027802616133834162
]Search in Google Scholar
[
23. Park S, Seo GS. Fecal microbiota transplantation: Where is it leading? Gastroenterol Hepatol 2014;10(5):307-9.
]Search in Google Scholar
[
24. Bibbò S, Settanni CR, Porcari S, Bocchino E, Ianiro G, Cammarota G, et al. Fecal microbiota transplantation: screening and selection to choose the optimal donor. J Clin Med 2020;9(6):1757.10.3390/jcm9061757735609932517023
]Search in Google Scholar
[
25. Bafeta A, Yavchitz A, Riveros C, Batista R, Ravaud P. Methods and reporting studies assessing fecal microbiota transplantation: a systematic review. Ann Intern Med 2017;167(1):34-9.10.7326/M16-281028531908
]Search in Google Scholar
[
26. Cohen NA, Livovsky DM, Yaakobovitch S, Ben Yehoyada M, Ben Ami R, Adler A, et al. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection. Isr Med Assoc J 2016;18(10):594-9.
]Search in Google Scholar
, 